Recent Quarter Total Invested
$349,708
-$776,046.00
Recent Quarter Institutional Ownership Percentage
15.37%
-$37.23
Total Invested of Last Quarter
$1.13 M
Ownership Percentage of Last Quarter
52.6%
Aptevo Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 516,789 | $94,000 | 193.66% | 4.11% |
| SABBY MANAGEMENT, LLC | 02/14/2024 | 349,471 | $63,254 | -73.81% | 2.78% |
| CITADEL ADVISORS LLC | 02/14/2024 | 262,124 | $47,444 | 100.00% | 2.08% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2024 | 159,000 | $28,778 | 11.34% | 1.26% |
| SQUAREPOINT OPS LLC | 02/14/2024 | 138,697 | $25,104 | 100.00% | 1.10% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 104,608 | $18,934 | 100.00% | 0.83% |
| VANGUARD GROUP INC | 03/11/2024 | 91,725 | $16,602 | -58.51% | 0.73% |
| ARMISTICE CAPITAL, LLC | 02/13/2024 | 61,130 | $11,065 | -95.05% | 0.49% |
| CANTOR FITZGERALD, L. P. | 02/14/2024 | 58,532 | $10,594 | 3.86% | 0.47% |
| BLACKROCK INC. | 02/13/2024 | 46,635 | $8,441 | -2.17% | 0.37% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2024 | 45,980 | $8,322 | 100.00% | 0.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 43,201 | $7,819 | -42.67% | 0.34% |
| BAADER BANK AKTIENGESELLSCHAFT | 02/08/2024 | 15,086 | $2,026 | 100.00% | 0.12% |
| NORTHERN TRUST CORP | 02/13/2024 | 14,121 | $2,556 | 0.00% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 13,660 | $2,472 | 1.22% | 0.11% |
| MORGAN STANLEY | 08/16/2024 | 11,370 | $2,058 | 3.24% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 02/14/2024 | 11,248 | $2,036 | 100.00% | 0.09% |
| FRANKLIN RESOURCES INC | 02/09/2024 | 10,997 | $1,990 | 0.00% | 0.09% |
| STATE STREET CORP | 02/14/2024 | 10,941 | $1,980 | 0.00% | 0.09% |
| DIVERGENT WEALTH ADVISORS | 02/09/2024 | 10,000 | $1,810 | 0.00% | 0.08% |
| JPMORGAN CHASE & CO | 02/12/2024 | 1,897 | $343 | -0.52% | 0.02% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 1,617 | $293 | 3.52% | 0.01% |
| FIFTH THIRD BANCORP | 01/19/2024 | 291 | $53 | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 03/22/2024 | 142 | $26 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/14/2024 | 95 | $17 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 30 | $5 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/24/2024 | 17 | $4 | 0.00% | 0.00% |
| CITIGROUP INC | 02/09/2024 | 10 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2024 | 6 | $1 | 0.00% | 0.00% |
| UBS GROUP AG | 02/09/2024 | 5 | $1 | -94.12% | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/16/2024 | 0 | $0 | -100.00% | 0.00% |
| EARNEST PARTNERS LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
Aptevo Therapeutics Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of APVO shares?
During the previous two years, 1 institutional investors and hedge funds held shares of Aptevo Therapeutics Inc.. The most heavily invested institutionals were:
QS Investors, LLC: 15,650
-
What percentage of Aptevo Therapeutics Inc. stock is owned by institutional investors?
15.37% of Aptevo Therapeutics Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at APVO ?
Institutional investors have bought a total of 15,650 shares in the last 24 months. This purchase volume represents approximately $4,382 in transactions.